Wealthfront Advisers LLC Invests $1.75 Million in Retractable Technologies, Inc. (NYSE:RVP)

Wealthfront Advisers LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned approximately 8.46% of Retractable Technologies at the end of the most recent reporting period.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Retractable Technologies in a research report on Tuesday. They set a “hold” rating for the company.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.73 on Friday. The stock has a 50-day moving average of $0.79 and a two-hundred day moving average of $0.75. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.23. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The stock has a market cap of $21.89 million, a P/E ratio of -1.35 and a beta of 2.08.

Retractable Technologies Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.